Efficacy of octreotide long-acting repeatable in neuroendocrine tumors: RADIANT-2 placebo arm post hoc analysis

Somatostatin analogues (SSA) have demonstrated antiproliferative activity in addition to efficacy for carcinoid symptom control in functional neuroendocrine tumors (NET). A post hoc analysis of the placebo arm of the RAD001 In Advanced Neuroendocrine Tumors-2 (RADIANT-2) study was conducted to asses...

Descripción completa

Detalles Bibliográficos
Autores principales: Strosberg, Jonathan R, Yao, James C, Bajetta, Emilio, Aout, Mounir, Bakker, Bert, Hainsworth, John D, Ruszniewski, Philippe B, Van Cutsem, Eric, Öberg, Kjell, Pavel, Marianne E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bioscientifica Ltd 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609826/
https://www.ncbi.nlm.nih.gov/pubmed/26373569
http://dx.doi.org/10.1530/ERC-15-0314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4609826/
https://www.ncbi.nlm.nih.gov/pubmed/26373569
http://dx.doi.org/10.1530/ERC-15-0314

Ejemplares similares